Literature DB >> 22150718

Value-based insurance design: more health at any price.

A Mark Fendrick1, Jenifer J Martin, Alison E Weiss.   

Abstract

When everyone is required to pay the same out-of-pocket amount for health care services regardless of clinical indication, there is evidence of underuse of high-value services and overuse of interventions of no or marginal clinical benefit. Unlike most current health plan designs, value-based insurance design (V-BID) acknowledges heterogeneity of clinical interventions and patient characteristics. It encourages the use of services with strong evidence of clinical benefit and likewise discourages the use of low-value services. Implementing this concept into the national policy debate required a strategy that included conceptual framework development, program implementation, rigorous evaluation, media outreach, and an advocacy plan. Upon completion of this strategy involving several colleagues from multiple disciplines, Congress included language specifically authorizing V-BID in the Patient Protection and Affordable Care Act. A wide-ranging approach, planned as early as possible, can lead to the successful translation of health services research to policy. © Health Research and Educational Trust.

Entities:  

Mesh:

Year:  2011        PMID: 22150718      PMCID: PMC3393011          DOI: 10.1111/j.1475-6773.2011.01358.x

Source DB:  PubMed          Journal:  Health Serv Res        ISSN: 0017-9124            Impact factor:   3.402


  25 in total

1.  The quality of health care delivered to adults in the United States.

Authors:  Elizabeth A McGlynn; Steven M Asch; John Adams; Joan Keesey; Jennifer Hicks; Alison DeCristofaro; Eve A Kerr
Journal:  N Engl J Med       Date:  2003-06-26       Impact factor: 91.245

Review 2.  The effects of prescription drug cost sharing: a review of the evidence.

Authors:  Teresa B Gibson; Ronald J Ozminkowski; Ron Z Goetzel
Journal:  Am J Manag Care       Date:  2005-11       Impact factor: 2.229

3.  Value-based insurance design: a "clinically sensitive" approach to preserve quality of care and contain costs.

Authors:  A Mark Fendrick; Michael E Chernew
Journal:  Am J Manag Care       Date:  2006-01       Impact factor: 2.229

Review 4.  Value-based insurance design.

Authors:  Michael E Chernew; Allison B Rosen; A Mark Fendrick
Journal:  Health Aff (Millwood)       Date:  2007-01-30       Impact factor: 6.301

5.  Unintended consequences of caps on Medicare drug benefits.

Authors:  John Hsu; Mary Price; Jie Huang; Richard Brand; Vicki Fung; Rita Hui; Bruce Fireman; Joseph P Newhouse; Joseph V Selby
Journal:  N Engl J Med       Date:  2006-06-01       Impact factor: 91.245

6.  A benefit-based copay for prescription drugs: patient contribution based on total benefits, not drug acquisition cost.

Authors:  A M Fendrick; D G Smith; M E Chernew; S N Shah
Journal:  Am J Manag Care       Date:  2001-09       Impact factor: 2.229

7.  Varying pharmacy benefits with clinical status: the case of cholesterol-lowering therapy.

Authors:  Dana P Goldman; Geoffrey F Joyce; Pinar Karaca-Mandic
Journal:  Am J Manag Care       Date:  2006-01       Impact factor: 2.229

8.  Cost-effectiveness of full medicare coverage of angiotensin-converting enzyme inhibitors for beneficiaries with diabetes.

Authors:  Allison B Rosen; Mary Beth Hamel; Milton C Weinstein; David M Cutler; A Mark Fendrick; Sandeep Vijan
Journal:  Ann Intern Med       Date:  2005-07-19       Impact factor: 25.391

9.  Effect of a medication copayment increase in veterans with schizophrenia.

Authors:  John E Zeber; Kyle L Grazier; Marcia Valenstein; Frederic C Blow; Paula M Lantz
Journal:  Am J Manag Care       Date:  2007-06       Impact factor: 2.229

10.  Value-based insurance design: a "clinically sensitive, fiscally responsible" approach to mitigate the adverse clinical effects of high-deductible consumer-directed health plans.

Authors:  A Mark Fendrick; Michael E Chernew
Journal:  J Gen Intern Med       Date:  2007-06       Impact factor: 5.128

View more
  4 in total

1.  Building a bridge to somewhere better: linking health care research and health policy.

Authors:  Matthew M Davis; Cary P Gross; Carolyn M Clancy
Journal:  Health Serv Res       Date:  2012-02       Impact factor: 3.402

2.  Use of advanced treatment technologies among men at low risk of dying from prostate cancer.

Authors:  Bruce L Jacobs; Yun Zhang; Florian R Schroeck; Ted A Skolarus; John T Wei; James E Montie; Scott M Gilbert; Seth A Strope; Rodney L Dunn; David C Miller; Brent K Hollenbeck
Journal:  JAMA       Date:  2013-06-26       Impact factor: 56.272

3.  Analysing coverage decision-making: opening Pandora's box?

Authors:  Katharina Elisabeth Fischer; Reiner Leidl
Journal:  Eur J Health Econ       Date:  2014-02-06

4.  Controlling health costs: physician responses to patient expectations for medical care.

Authors:  Amber K Sabbatini; Jon C Tilburt; Eric G Campbell; Robert D Sheeler; Jason S Egginton; Susan D Goold
Journal:  J Gen Intern Med       Date:  2014-05-29       Impact factor: 5.128

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.